NZ597024A - Cardiovascular related uses of il-1beta antibodies and binding fragments thereof - Google Patents
Cardiovascular related uses of il-1beta antibodies and binding fragments thereofInfo
- Publication number
- NZ597024A NZ597024A NZ597024A NZ59702410A NZ597024A NZ 597024 A NZ597024 A NZ 597024A NZ 597024 A NZ597024 A NZ 597024A NZ 59702410 A NZ59702410 A NZ 59702410A NZ 597024 A NZ597024 A NZ 597024A
- Authority
- NZ
- New Zealand
- Prior art keywords
- subject
- cardiovascular
- cardiovascular event
- binding fragments
- related uses
- Prior art date
Links
- 239000012634 fragment Substances 0.000 title abstract 3
- 230000002526 effect on cardiovascular system Effects 0.000 title abstract 2
- 230000007211 cardiovascular event Effects 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 208000004476 Acute Coronary Syndrome Diseases 0.000 abstract 1
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 206010007559 Cardiac failure congestive Diseases 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 208000010496 Heart Arrest Diseases 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 230000000250 revascularization Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/245—IL-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18267909P | 2009-05-29 | 2009-05-29 | |
| US25257109P | 2009-10-16 | 2009-10-16 | |
| US31300110P | 2010-03-11 | 2010-03-11 | |
| PCT/US2010/036761 WO2010138939A1 (en) | 2009-05-29 | 2010-05-28 | CARDIOVASCULAR RELATED USES OF IL-1ß ANTIBODIES AND BINDING FRAGMENTS THEREOF |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ597024A true NZ597024A (en) | 2014-01-31 |
Family
ID=43223130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ597024A NZ597024A (en) | 2009-05-29 | 2010-05-28 | Cardiovascular related uses of il-1beta antibodies and binding fragments thereof |
Country Status (15)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150094344A1 (en) * | 2011-04-01 | 2015-04-02 | The Medicines Company | Short-acting dihydropyridines (clevidipine) for use in reducing stroke damage |
| AR088083A1 (es) * | 2011-09-30 | 2014-05-07 | Novartis Ag | USO DE ANTICUERPOS DE UNION A IL-1b |
| ES2534782T3 (es) * | 2012-02-02 | 2015-04-28 | Baylor College Of Medicine | Sistema biológico de administración y expresión basado en adenovirus para uso en el tratamiento de la osteoartritis |
| CN103588878A (zh) * | 2012-08-15 | 2014-02-19 | 江苏泰康生物医药有限公司 | 一种人源化抗人白细胞介素1 β单克隆抗体及其制备与应用 |
| EP3524621A1 (en) * | 2012-10-04 | 2019-08-14 | XBiotech, Inc | Treating vascular disease and complications thereof |
| CA2891556A1 (en) * | 2012-11-16 | 2014-05-22 | Novartis Ag | Use of il-1 beta binding antibodies for treating peripheral arterial disease |
| US10000557B2 (en) * | 2012-12-19 | 2018-06-19 | Dnae Group Holdings Limited | Methods for raising antibodies |
| CN103059136A (zh) * | 2012-12-24 | 2013-04-24 | 浙江大学 | 抗中华鳖IL-1β多克隆抗体的制备及在检测中的应用 |
| KR102337954B1 (ko) * | 2018-08-16 | 2021-12-10 | 차의과학대학교 산학협력단 | 뇌졸중 치료용 조성물 및 이를 스크리닝하는 방법 |
| JP2022531328A (ja) * | 2019-05-03 | 2022-07-06 | ユニバーシティ・オブ・チューリッヒ | 脳虚血再灌流傷害の治療 |
| US20220275079A1 (en) * | 2020-11-20 | 2022-09-01 | The General Hospital Corporation | Clonal Hematopoiesis and Risk of Chronic Liver Disease |
| GB202400340D0 (en) | 2024-01-10 | 2024-02-21 | Wotherspoon Hugh Robert | IL-1B binding antibody |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7820383B2 (en) * | 1997-03-10 | 2010-10-26 | Interleukin Genetics, Inc. | Method for diagnosing myocardial infarction |
| AR016551A1 (es) * | 1997-07-30 | 2001-07-25 | Smithkline Beecham Corp | Derivados de 2-oxindol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos |
| US6635249B1 (en) * | 1999-04-23 | 2003-10-21 | Cenes Pharmaceuticals, Inc. | Methods for treating congestive heart failure |
| US7860583B2 (en) * | 2004-08-25 | 2010-12-28 | Carefusion 303, Inc. | System and method for dynamically adjusting patient therapy |
| EP1379197A4 (en) * | 2001-03-23 | 2009-06-03 | Durect Corp | DISPOSAL OF MEDICINAL PRODUCTS OF DELAYED RELEASE DEVICES IMPLANTED IN MYOKARD TISSUE OR PER ICARDROOM |
| US20040106954A1 (en) * | 2002-11-15 | 2004-06-03 | Whitehurst Todd K. | Treatment of congestive heart failure |
| WO2004100987A2 (en) | 2003-05-06 | 2004-11-25 | Regeneron Pharmaceuticals, Inc. | Methods of using il-1 antagonists to treat neointimal hyperplasia |
| EP1851245B1 (en) * | 2005-01-26 | 2012-10-10 | Amgen Fremont Inc. | Antibodies against interleukin-1 beta |
| US20060171948A1 (en) * | 2005-02-02 | 2006-08-03 | Weinstein Steven P | Methods of using IL-1 antagonists to reduce C-reactive protein |
| WO2006084145A2 (en) * | 2005-02-02 | 2006-08-10 | Regeneron Pharmaceuticals, Inc. | Methods of using il-1 antagonists to reduce c-reactive protein |
| US9296816B2 (en) | 2005-04-15 | 2016-03-29 | Macrogenics, Inc. | Covalent diabodies and uses thereof |
| ES2335232T3 (es) * | 2005-06-21 | 2010-03-23 | Xoma Technology Ltd. | Anticuerpos y fragmentos de los mismos que se unen a la il-1 beta. |
| WO2007042524A2 (en) | 2005-10-14 | 2007-04-19 | Novo Nordisk A/S | Treating diabetes using inhibitors of il-1 |
| JP4524275B2 (ja) * | 2006-09-01 | 2010-08-11 | 日本ポリプロ株式会社 | ビニル基および極性基含有プロピレン系共重合体及びそれを用いる重合体の製造方法。 |
| JP5645409B2 (ja) * | 2006-12-20 | 2014-12-24 | ゾーマ （ユーエス） リミテッド ライアビリティ カンパニー | ＩＬ−１β関連疾患の治療方法 |
-
2010
- 2010-05-28 CN CN201710537454.6A patent/CN107243077A/zh active Pending
- 2010-05-28 CN CN2010800330317A patent/CN102573893A/zh active Pending
- 2010-05-28 JP JP2012513346A patent/JP5763625B2/ja active Active
- 2010-05-28 BR BRPI1011228A patent/BRPI1011228A2/pt not_active IP Right Cessation
- 2010-05-28 MX MX2011012666A patent/MX2011012666A/es active IP Right Grant
- 2010-05-28 KR KR1020117031198A patent/KR20120061041A/ko not_active Withdrawn
- 2010-05-28 NZ NZ597024A patent/NZ597024A/en not_active IP Right Cessation
- 2010-05-28 EP EP10781360A patent/EP2435073A4/en not_active Withdrawn
- 2010-05-28 SG SG10201500180RA patent/SG10201500180RA/en unknown
- 2010-05-28 SG SG2011087723A patent/SG176265A1/en unknown
- 2010-05-28 WO PCT/US2010/036761 patent/WO2010138939A1/en not_active Ceased
- 2010-05-28 EA EA201101643A patent/EA201101643A1/ru unknown
- 2010-05-28 CA CA2763161A patent/CA2763161A1/en not_active Abandoned
- 2010-05-28 AU AU2010253924A patent/AU2010253924B2/en not_active Ceased
- 2010-05-28 SG SG2014014534A patent/SG2014014534A/en unknown
- 2010-05-28 US US12/790,738 patent/US20100316651A1/en not_active Abandoned
-
2011
- 2011-11-28 IL IL216660A patent/IL216660A0/en unknown
-
2015
- 2015-01-06 JP JP2015000602A patent/JP2015120704A/ja active Pending
-
2017
- 2017-07-11 US US15/647,203 patent/US10611832B2/en active Active
-
2018
- 2018-04-09 HK HK18104608.6A patent/HK1245111A1/zh unknown
-
2020
- 2020-02-24 US US16/799,707 patent/US20210009679A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| SG2014014534A (en) | 2014-07-30 |
| SG176265A1 (en) | 2012-01-30 |
| AU2010253924A1 (en) | 2012-01-19 |
| JP2012528796A (ja) | 2012-11-15 |
| WO2010138939A1 (en) | 2010-12-02 |
| US20100316651A1 (en) | 2010-12-16 |
| SG10201500180RA (en) | 2015-03-30 |
| US20210009679A1 (en) | 2021-01-14 |
| CN102573893A (zh) | 2012-07-11 |
| CN107243077A (zh) | 2017-10-13 |
| US10611832B2 (en) | 2020-04-07 |
| MX2011012666A (es) | 2011-12-16 |
| JP5763625B2 (ja) | 2015-08-12 |
| EP2435073A4 (en) | 2013-03-27 |
| CA2763161A1 (en) | 2010-12-02 |
| US20180155420A1 (en) | 2018-06-07 |
| EA201101643A1 (ru) | 2012-12-28 |
| JP2015120704A (ja) | 2015-07-02 |
| BRPI1011228A2 (pt) | 2019-09-24 |
| HK1245111A1 (zh) | 2018-08-24 |
| EP2435073A1 (en) | 2012-04-04 |
| KR20120061041A (ko) | 2012-06-12 |
| AU2010253924B2 (en) | 2015-01-22 |
| IL216660A0 (en) | 2012-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ597024A (en) | Cardiovascular related uses of il-1beta antibodies and binding fragments thereof | |
| You et al. | Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | |
| NI201000034A (es) | Activadores de guanilato ciclasas solubles. | |
| BR112012015147A2 (pt) | conjugado de complexo de agente e pelo menos um ligante localizador de alvo, análogo de prostaciclina, e, composição terapêutica para o tratamento de distúrbios pulmonares | |
| RU2014132591A (ru) | Титановые сплавы | |
| JP2013501166A5 (cg-RX-API-DMAC7.html) | ||
| WO2010049678A3 (en) | Treatment of energy utilization diseases | |
| JP2011500690A5 (cg-RX-API-DMAC7.html) | ||
| FI3581650T3 (fi) | IX-tekijän polypeptidimutantti, sen käyttöjä ja menetelmä sen valmistamiseksi | |
| BR112013032375A2 (pt) | conjugado compreendendo oxintomodulina e um fragmento de imunoglobulina, e seus usos | |
| ATE429825T1 (de) | Abgepacktes konzentrat zur zubereitung von bouillon, suppe, sauce, tunke oder zur verwendung als würze sowie das konzentrat mit modifizierter stärke | |
| GT201200341A (es) | Utilizaciòn de la asociaciòn de un ihibidor de la correinte sinusal if y de un inhibidor de la enzima de conversiòn de la angiotensina para el tratamiento de la insuficiencia cardiaca | |
| JP2018513846A5 (cg-RX-API-DMAC7.html) | ||
| PH12015502100A1 (en) | Reducing the risk of autoimmune disease | |
| GT200500266A (es) | Nuevos derivados de pirimidina y su uso | |
| CY1105638T1 (el) | Xρηση του μεταβολιτη της βαλσαρτανης για την αναστoλη της αιμοπεταλιακης συσσωρευσης | |
| CY1120332T1 (el) | Μιμητικα καλσιτονινης για τη θεραπεια των ασθενειων και των διαταραχων | |
| Goldenberg et al. | Implantable cardioverter defibrillator efficacy and chronic kidney disease: competing risks of arrhythmic and nonarrhythmic mortality. | |
| WO2015175502A3 (en) | Replacement therapy for natriuretic peptide deficiencies | |
| Cheng | Prevalence, profile, predictors, and natural history of aspirin resistance measured by the Ultegra Rapid Platelet Function Assay-ASA in patients with coronary artery disease. | |
| WO2015039036A3 (en) | Novel cytochrome p450 inhibitors and their method of use | |
| Heilbron et al. | Management of atrial fibrillation in the emergency department and following acute myocardial infarction. | |
| Jang et al. | A Case of Pheochromocytoma Presenting as Stress-Induced Cardiomyopathy with Large Left Ventricular Thrombus | |
| Antz et al. | Oral anticoagulation for atrial fibrillation | |
| Kryuchkova et al. | Effectiveness of perindopril and amlodipine combination in hypertensives with COPD |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 28 MAY 2017 BY SHELSTON IP Effective date: 20140502 |
|
| ASS | Change of ownership |
Owner name: XOMA (US) LLC, US Effective date: 20150730 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 MAY 2018 BY COMPUTER PACKAGES INC Effective date: 20170502 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 MAY 2019 BY COMPUTER PACKAGES INC Effective date: 20180501 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 MAY 2020 BY COMPUTER PACKAGES INC Effective date: 20190501 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 MAY 2021 BY COMPUTER PACKAGES INC Effective date: 20200501 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 MAY 2022 BY COMPUTER PACKAGES INC Effective date: 20210430 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 MAY 2023 BY COMPUTER PACKAGES INC Effective date: 20220430 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 MAY 2024 BY COMPUTER PACKAGES INC Effective date: 20230430 |
|
| LAPS | Patent lapsed |